Network Bio partners with Duke University on AI disease models
Network Bio will work alongside researchers at Duke to conduct profiling on tissue and blood samples.
Drug Development
Bio-Thera gains Chinese approval for spondylitis and rheumatoid arthritis drug
Armada to combine with Brains Bioceutical in $750m deal
Alfasigma receives EC’s expanded approval for filgotinib to treat axSpA
Evommune signs $1.1bn licence deal with Hinova for EVO570
PharmatrophiX and Circular partner on neurodegenerative drugs
GEBRO and Spektus sign collaboration for ActraFlex
FDA to review uniQure’s BLA for Huntington’s gene therapy
